Education
About Us
Working with TipRanks
Follow Us
Tilray (TLRY)
NASDAQ:TLRY
TLRY Stock Chart & Stats
Day’s Range―(―) - ― (―)
52-Week Range$0.41(+8.96%) - $2.15 (-377.78%)
Previous CloseN/A
Volume22.72M
Average Volume (3M)25.79M
Market Cap
$464.67M
Enterprise ValueN/A
Total Cash (Recent Filing)$248.41M
Total Debt (Recent Filing)C$343.91M
Price to Earnings (P/E)―
Beta1.32
Next Earnings
Jul 23, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.87
Shares Outstanding1,025,530,500
10 Day Avg. Volume21,728,499
30 Day Avg. Volume25,788,330
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.14
Price to Sales (P/S)0.00
P/FCF Ratio-5.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$0.93Price Target Upside106.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Tilray News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAdjusted EBITDA exceeded expectations, driven by better-than-expected Canadian cannabis gross margins.
Growth ProspectsManagement expects stronger performance in the fourth fiscal quarter due to seasonal growth in acquired brands.
Operational ImprovementsCapital investments in a new facility are expected to enhance Canadian adult-use trends by optimizing the use of byproducts for vapes and infused pre-rolls.
Bears Say
EarningsTilray reported third-quarter sales of $186M, falling short of both company and consensus estimates.
Market ChallengesThe craft beer category and Canadian cannabis markets are under competitive pressure, affecting Tilray's outlook.
Regulatory EnvironmentThe lack of clarity regarding the path to federal legalization of cannabis in the U.S. impacts future prospects.
Ownership Overview
0.56% Insiders
0.39% Mutual Funds
1.08% Other Institutional Investors
97.08% Public Companies and Individual Investors
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was $0.41 and its highest was $2.15 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is $464.67M.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Jul 23, 2025 which is in 62 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Apr 08, 2025. The company reported -$0.87 earnings per share for the quarter, missing the consensus estimate of -$0.038 by -$0.832.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is -0.02.
How many shares outstanding does Tilray have?
Tilray has 1,025,530,500 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -$0.87 in its last earnings report, missing expectations of -$0.038. Following the earnings report the stock price went down -20.69%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TLRY
Tilray Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.93 (106.67% Upside)
$0.93 (106.67% Upside)
Blogger Sentiment
Bullish
TLRY Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 6.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $35.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 3.5%
Last 30 Days ▼ 3.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-76.70%
12-Months-Change
Fundamentals
Return on Equity
-31.06%
Trailing 12-Months
Asset Growth
-19.22%
Trailing 12-Months
Company Description
Tilray
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
TLRY Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented both positive and negative aspects. While there were notable improvements in cannabis gross margins and international growth, significant challenges remain, particularly with net revenue decline and a substantial net loss due to non-cash impairment. The beverage segment showed mixed results with some areas of growth, but overall sales volumes faced challenges.Read More>TLRY Stock 12 Month Forecast
Average Price Target
$0.93
▲(106.67% Upside)